Utah Medical Products stock trades at EUR 66.00 ahead of results

Published on 10/08/2026 at 13:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half 2026 sales fell 12.00 percent year over year. Utah Medical Products stock stood at EUR 66.00 on October 8, 2026, versus EUR 65.50.

UTMD, US9174881089, Illustration mit AI erstellt.

Utah Medical Products (ISIN US9174881089) was trading at EUR 66.00 at Lang & Schwarz on October 8, 2026 at 1:01 p.m. CEST, up 0.76 percent versus the prior close of EUR 65.50. StockTitan reported on October 5, 2026 that calendar third-quarter results are scheduled for October 22, 2026. The upcoming report will put the recent decline in sales and profit back under scrutiny.

Results date sets the next test

The October 22 reporting date gives the market a defined checkpoint for Utah Medical Products. The company serves labor and delivery departments, neonatal intensive care units and women's health providers with disposable and reusable specialty medical devices, according to its investor-relations page.

The scheduled results matter because the first-half comparison was weaker. StockTitan's summary of the September 24, 2026 tender-offer filing states that first-half 2026 sales were 12.00 percent lower than in the same period of 2025 and net profits were 13.00 percent lower. The same filing reported trailing-twelve-month EBITDA of USD 15.7 million, giving investors an additional profitability measure alongside the reported decline.

Medical devices remain the core business

Utah Medical Products sells fetal monitoring accessories, vacuum-assisted delivery systems, infant respiratory hoods, catheters, pressure-monitoring products and gynecological devices. Its investor-relations page says the company develops, manufactures and markets specialty devices for healthcare providers in more than 100 countries, with particular emphasis on women and babies.

Stock remains below its yearly high

The USD 233.9 million market capitalization and USD 53.66 to USD 76.89 52-week range, both dated October 7, 2026, place UTMD in the small-cap medical-device segment. The euro quote of EUR 66.00 is a separate German-market reference and is not combined with the Nasdaq figures. For investors, the October report offers the clearest next comparison point for judging whether the first-half contraction is continuing.

Price holds above the prior close

At Lang & Schwarz, UTMD was trading at EUR 66.00 on October 8, 2026 at 1:01 p.m. CEST, plus 0.76 percent versus the prior close of EUR 65.50. The further course of trading is shown by the continuously updated real-time quote of Utah Medical Products stock.